Literature DB >> 8474494

Postneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin.

A Fève1, B Angelard, G Fénelon, M Logak, A Guillard, J Lacau Saint-Guily.   

Abstract

We report a case of laryngeal dyskinesia resulting in severe rest and exercise dyspnea. A 51-year-old man treated for 2 years with flupentixol, an incisive neuroleptic, developed severe dyspnea due to intermittent, rhythmic, and dystonic movements of the vocal cords and upper airway. Local injections of botulinum toxin resulted in spectacular regression of laryngeal spasms and major improvement in breathing. This case emphasizes the risk of upper respiratory dyskinesias associated with neuroleptic treatment and shows the feasibility of a new local treatment in this life-threatening disorder.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8474494     DOI: 10.1002/mds.870080220

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  5 in total

1.  Spasmodic laryngeal dyspnea: a rare manifestation of laryngeal dystonia.

Authors:  P Zwirner; D Dressler; E Kruse
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

Review 2.  Movement disorder emergencies.

Authors:  Steven J Frucht
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

3.  Laryngeal tardive dyskinesia.

Authors:  A Fève; B Angelard; J Lacau St Guily
Journal:  J Neurol       Date:  1995-07       Impact factor: 4.849

Review 4.  Movement disorder emergencies.

Authors:  Kathleen L Poston; Steven J Frucht
Journal:  J Neurol       Date:  2008-08       Impact factor: 4.849

5.  Botulinum toxin injection in laryngeal dyspnea.

Authors:  Virginie Woisard; Xuelai Liu; Marie Christine Arné Bes; Marion Simonetta-Moreau
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-06       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.